David M. Urso - 02 Jun 2023 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role
President and CEO, Director
Signature
/s/ Brian G. Drazba, as attorney in fact
Issuer symbol
MEIP
Transactions as of
02 Jun 2023
Net transactions value
$0
Form type
4
Filing time
06 Jun 2023, 16:37:36 UTC
Previous filing
07 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MEIP Stock Option (Right to Buy) Award $0 +166,571 $0.000000 166,571 02 Jun 2023 Common Stock 166,571 $7.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter of such options shall vest on June 2, 2024, and the remaining three quarters of such options shall vest monthly over a three year period beginning on June 2, 2024.